Arcus Biosciences, Inc.
US ˙ NYSE ˙ US03969F1093

SecurityRCUS / Arcus Biosciences, Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in RCUS / Arcus Biosciences, Inc.

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Arcus Biosciences, Inc. (US:RCUS) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 379,100 shares of Arcus Biosciences, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ARCUS BIOSCIENCES COM 03969F109 0 -100.00 0
2025-11-13 2025-09-30 13F ARCUS BIOSCIENCES COM 03969F109 379,100 0 0.00 5,156 67.08 0.0060
2025-08-14 2025-06-30 13F ARCUS BIOSCIENCES COM 03969F109 379,100 0 0.00 3,086 3.70 0.0038
2025-08-14 2025-03-31 13F/A-1 ARCUS BIOSCIENCES COM 03969F109 379,100 0 0.00 2,976 -47.28 0.0037
2025-05-15 2025-03-31 13F ARCUS BIOSCIENCES COM 03969F109 379,100 0 2,976 0.0024
2025-02-14 2024-12-31 13F ARCUS BIOSCIENCES COM 03969F109 379,100 0 0.00 5,645 -2.61 0.0068
2024-11-14 2024-09-30 13F ARCUS BIOSCIENCES COM 03969F109 379,100 0 0.00 5,796 0.38 0.0063
2024-08-09 2024-06-30 13F ARCUS BIOSCIENCES COM 03969F109 379,100 0 0.00 5,774 -19.32 0.0066
2024-05-14 2024-03-31 13F ARCUS BIOSCIENCES COM 03969F109 379,100 0 0.00 7,157 -1.16 0.0081
2024-02-14 2023-12-31 13F ARCUS BIOSCIENCES COM 03969F109 379,100 0 0.00 7,241 6.41 0.0084
2023-11-14 2023-09-30 13F ARCUS BIOSCIENCES COM 03969F109 379,100 0 0.00 6,805 -11.62 0.0085
2023-10-27 2023-06-30 13F/A-2 ARCUS BIOSCIENCES COM 03969F109 379,100 0 0.00 7,700 11.35 0.0088
2023-10-12 2023-06-30 13F/A-1 ARCUS BIOSCIENCES COM 03969F109 379,100 0 7,700 0.0077
2023-08-14 2023-06-30 13F ARCUS BIOSCIENCES COM 03969F109 379,100 0 7,700 0.0078
2023-06-01 2023-03-31 13F/A-1 ARCUS BIOSCIENCES COM 03969F109 379,100 0 0.00 6,915 -11.80 0.0082
2023-05-15 2023-03-31 13F ARCUS BIOSCIENCES COM 03969F109 379,100 0 6,915 0.0063
2023-02-21 2022-12-31 13F ARCUS BIOSCIENCES COM 03969F109 379,100 -758 -0.20 7,840 -21.10 0.0093
2022-11-14 2022-09-30 13F ARCUS BIOSCIENCES COM 03969F109 379,858 -22 -0.01 9,937 3.23 0.0122
2022-08-17 2022-06-30 13F/A-1 ARCUS BIOSCIENCES COM 03969F109 379,880 0 0.00 9,626 -19.71 0.0108
2022-08-15 2022-06-30 13F ARCUS BIOSCIENCES COM 03969F109 379,880 0 9,626 0.0034
2022-05-16 2022-03-31 13F ARCUS BIOSCIENCES COM 03969F109 379,880 0 0.00 11,989 -22.02 0.0091
2022-02-11 2021-12-31 13F Arcus Biosciences COM 03969F109 379,880 -82,100 -17.77 15,374 -4.56 0.0128
2021-11-12 2021-09-30 13F ARCUS BIOSCIENCES COM 03969F109 461,980 -1,418 -0.31 16,109 26.59 0.0137
2021-08-13 2021-06-30 13F ARCUS BIOSCIENCES COM 03969F109 463,398 0 0.00 12,725 -2.21 0.0105
2021-05-14 2021-03-31 13F ARCUS BIOSCIENCES COM 03969F109 463,398 1,034 0.22 13,012 8.41 0.0184
2021-02-16 2020-12-31 13F ARCUS BIOSCIENCES COM 03969F109 462,364 0 0.00 12,003 51.46 0.0175
2020-11-13 2020-09-30 13F ARCUS BIOSCIENCES COM 03969F109 462,364 61,200 15.26 7,925 -20.15 0.0134
2020-08-11 2020-06-30 13F ARCUS BIOSCIENCES COM 03969F109 401,164 401,164 9,925 0.0171
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.